Samah Nassereddine[Author] - Search Results

Year	Number of Results
2016	1
2017	7
2018	2
2019	4
2021	3
2022	1
2023	1
2024	0

1

Perspectives and challenges of small molecule inhibitor therapy for FLT3-mutated acute myeloid leukemia.

Lap CJ, Abrahim MS, Nassereddine S. Lap CJ, et al. Among authors: nassereddine s. Ann Hematol. 2023 Nov 17. doi: 10.1007/s00277-023-05545-3. Online ahead of print. Ann Hematol. 2023. PMID: 37975931 Review.

2

Immune-based Therapies for Non-small Cell Lung Cancer.

Rafei H, El-Bahesh E, Finianos A, Nassereddine S, Tabbara I. Rafei H, et al. Among authors: nassereddine s. Anticancer Res. 2017 Feb;37(2):377-387. doi: 10.21873/anticanres.11330. Anticancer Res. 2017. PMID: 28179283 Review.

3

PD-1 signaling and inhibition in AML and MDS.

Haroun F, Solola SA, Nassereddine S, Tabbara I. Haroun F, et al. Among authors: nassereddine s. Ann Hematol. 2017 Sep;96(9):1441-1448. doi: 10.1007/s00277-017-3051-5. Epub 2017 Jun 22. Ann Hematol. 2017. PMID: 28643044 Review.

4

Bariatric venous thromboembolism prophylaxis: an update on the literature.

Hamadi R, Marlow CF, Nassereddine S, Taher A, Finianos A. Hamadi R, et al. Among authors: nassereddine s. Expert Rev Hematol. 2019 Sep;12(9):763-771. doi: 10.1080/17474086.2019.1634542. Epub 2019 Aug 5. Expert Rev Hematol. 2019. PMID: 31219356 Review.

5

Acute Graft Versus Host Disease: A Comprehensive Review.

Nassereddine S, Rafei H, Elbahesh E, Tabbara I. Nassereddine S, et al. Anticancer Res. 2017 Apr;37(4):1547-1555. doi: 10.21873/anticanres.11483. Anticancer Res. 2017. PMID: 28373413 Review.

6

Acute Myeloid Leukemia Following Myeloproliferative Neoplasms: A Review of What We Know, What We Do Not Know, and Emerging Treatment Strategies.

McKinnell Z, Karel D, Tuerff D, Sh Abrahim M, Nassereddine S. McKinnell Z, et al. Among authors: nassereddine s. J Hematol. 2022 Dec;11(6):197-209. doi: 10.14740/jh1042. Epub 2022 Dec 1. J Hematol. 2022. PMID: 36632576 Free PMC article. Review.

7

Integrating Genomics in Myelodysplastic Syndrome to Predict Outcomes After Allogeneic Hematopoietic Cell Transplantation.

Nassereddine S, Nishihori T, Padron E, Mahfouz R, Bazarbachi A, Komrokji RS, Kharfan-Dabaja MA. Nassereddine S, et al. Clin Lymphoma Myeloma Leuk. 2017 Jan;17(1):7-13. doi: 10.1016/j.clml.2016.09.005. Epub 2016 Sep 16. Clin Lymphoma Myeloma Leuk. 2017. PMID: 27771290 Review.

8

Sinusoidal Obstruction Syndrome (Veno-occlusive Disease) Following Hematopoietic Stem Cell Transplant: Insights and Therapeutic Advances.

Nassereddine S, Alsubait S, Tabbara I. Nassereddine S, et al. Anticancer Res. 2018 May;38(5):2597-2605. doi: 10.21873/anticanres.12501. Anticancer Res. 2018. PMID: 29715079 Review.

9

Novel Biological Insights and New Developments in Management of Burkitt Lymphoma and High-Grade B-Cell Lymphoma.

Lap CJ, Nassereddine S, Dunleavy K. Lap CJ, et al. Among authors: nassereddine s. Curr Treat Options Oncol. 2021 Jun 7;22(7):60. doi: 10.1007/s11864-021-00857-w. Curr Treat Options Oncol. 2021. PMID: 34097157 Review.

10

Evaluating ivosidenib for the treatment of relapsed/refractory AML: design, development, and place in therapy.

Nassereddine S, Lap CJ, Tabbara IA. Nassereddine S, et al. Onco Targets Ther. 2018 Dec 28;12:303-308. doi: 10.2147/OTT.S182443. eCollection 2019. Onco Targets Ther. 2018. PMID: 30643428 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

17 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year